- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 221/22 - Systèmes cycliques pontés
Détention brevets de la classe C07D 221/22
Brevets de cette classe: 228
Historique des publications depuis 10 ans
|
12
|
9
|
19
|
16
|
9
|
11
|
8
|
19
|
6
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4490 |
7 |
| Alkermes Pharma Ireland Limited | 254 |
7 |
| Bristol-myers Squibb Company | 4756 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3376 |
6 |
| SpecGx LLC | 186 |
6 |
| Yunnan Haopy Pharmaceuticals Ltd | 8 |
6 |
| Merck Patent GmbH | 5772 |
5 |
| Takeda Pharmaceutical Company Limited | 2704 |
5 |
| Rensselaer Polytechnic Institute | 858 |
5 |
| Yale University | 2584 |
5 |
| Board of Regents, The University of Texas System | 6225 |
4 |
| University of Florida Research Foundation, Inc. | 4232 |
4 |
| Southwest Jiaotong University | 201 |
4 |
| Universite de Rouen | 98 |
4 |
| Purdue Pharma L.P. | 431 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 886 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3034 |
3 |
| C4 Theraprutics, Inc. | 65 |
3 |
| Merck Sharp & Dohme LLC | 3723 |
3 |
| F. Hoffmann-La Roche AG | 7777 |
2 |
| Autres propriétaires | 137 |